 Mamuka Kvaratskhelia
Concepts (403)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| HIV Integrase | 35 | 2023 | 67 | 9.800 |
Why?
| | HIV-1 | 43 | 2022 | 768 | 8.550 |
Why?
| | HIV Integrase Inhibitors | 24 | 2023 | 62 | 7.410 |
Why?
| | Virus Integration | 17 | 2022 | 68 | 3.070 |
Why?
| | Protein Multimerization | 9 | 2020 | 157 | 2.640 |
Why?
| | Intercellular Signaling Peptides and Proteins | 11 | 2021 | 347 | 2.530 |
Why?
| | Virus Replication | 10 | 2021 | 395 | 2.300 |
Why?
| | DNA, Viral | 11 | 2022 | 349 | 1.720 |
Why?
| | Anti-HIV Agents | 5 | 2022 | 663 | 1.610 |
Why?
| | Protein Binding | 42 | 2021 | 1888 | 1.600 |
Why?
| | Virion | 7 | 2022 | 73 | 1.600 |
Why?
| | RNA, Viral | 13 | 2022 | 565 | 1.540 |
Why?
| | HEK293 Cells | 22 | 2020 | 590 | 1.350 |
Why?
| | HIV Infections | 15 | 2023 | 2453 | 1.330 |
Why?
| | Capsid | 5 | 2022 | 74 | 1.250 |
Why?
| | Integrases | 6 | 2017 | 116 | 1.200 |
Why?
| | Leukemia Virus, Murine | 4 | 2016 | 16 | 1.130 |
Why?
| | Drug Resistance, Viral | 4 | 2017 | 99 | 1.110 |
Why?
| | Allosteric Regulation | 13 | 2023 | 81 | 1.060 |
Why?
| | Gene Products, gag | 4 | 2018 | 36 | 1.050 |
Why?
| | Mass Spectrometry | 15 | 2017 | 622 | 1.030 |
Why?
| | Antiviral Agents | 5 | 2023 | 642 | 0.980 |
Why?
| | Endodeoxyribonucleases | 8 | 2001 | 59 | 0.980 |
Why?
| | Pyridines | 2 | 2019 | 419 | 0.960 |
Why?
| | Nucleosomes | 3 | 2022 | 122 | 0.960 |
Why?
| | Human T-lymphotropic virus 1 | 7 | 2023 | 23 | 0.960 |
Why?
| | Acetates | 3 | 2014 | 94 | 0.930 |
Why?
| | Mutation, Missense | 3 | 2014 | 294 | 0.890 |
Why?
| | Genome, Viral | 4 | 2021 | 118 | 0.850 |
Why?
| | Models, Molecular | 22 | 2019 | 1368 | 0.830 |
Why?
| | Nuclear Proteins | 5 | 2016 | 591 | 0.830 |
Why?
| | Prions | 1 | 2022 | 33 | 0.810 |
Why?
| | Transcription Factors | 7 | 2017 | 1526 | 0.800 |
Why?
| | HIV Seropositivity | 1 | 2022 | 109 | 0.770 |
Why?
| | HIV Reverse Transcriptase | 6 | 2019 | 29 | 0.690 |
Why?
| | Vesicular Transport Proteins | 1 | 2021 | 82 | 0.690 |
Why?
| | Gene Products, pol | 1 | 2017 | 6 | 0.590 |
Why?
| | Sulfolobus | 7 | 2001 | 11 | 0.580 |
Why?
| | Quinolines | 3 | 2014 | 129 | 0.570 |
Why?
| | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 7 | 2014 | 134 | 0.560 |
Why?
| | Protein Structure, Tertiary | 13 | 2016 | 796 | 0.550 |
Why?
| | Protein Interaction Domains and Motifs | 6 | 2019 | 129 | 0.540 |
Why?
| | DNA | 12 | 2014 | 1350 | 0.530 |
Why?
| | Archaeal Proteins | 3 | 2001 | 45 | 0.530 |
Why?
| | Recombinant Proteins | 6 | 2013 | 1228 | 0.510 |
Why?
| | Recombination, Genetic | 6 | 2001 | 176 | 0.510 |
Why?
| | Crystallography, X-Ray | 6 | 2020 | 402 | 0.500 |
Why?
| | Binding Sites | 14 | 2021 | 1166 | 0.490 |
Why?
| | Protein Conformation | 12 | 2018 | 803 | 0.480 |
Why?
| | Amino Acid Sequence | 18 | 2019 | 1981 | 0.480 |
Why?
| | Humans | 59 | 2023 | 114045 | 0.480 |
Why?
| | Moloney murine leukemia virus | 1 | 2014 | 11 | 0.470 |
Why?
| | HeLa Cells | 5 | 2020 | 563 | 0.460 |
Why?
| | Transcription Initiation Site | 2 | 2014 | 40 | 0.460 |
Why?
| | Viral Proteins | 5 | 2016 | 281 | 0.450 |
Why?
| | Molecular Sequence Data | 18 | 2015 | 2783 | 0.440 |
Why?
| | Capsid Proteins | 3 | 2022 | 68 | 0.430 |
Why?
| | Acquired Immunodeficiency Syndrome | 1 | 2015 | 212 | 0.430 |
Why?
| | Cell Cycle Proteins | 6 | 2017 | 549 | 0.430 |
Why?
| | Nucleic Acid Conformation | 9 | 2021 | 670 | 0.430 |
Why?
| | Host-Pathogen Interactions | 5 | 2021 | 295 | 0.420 |
Why?
| | Nuclear Pore Complex Proteins | 3 | 2022 | 31 | 0.420 |
Why?
| | beta Karyopherins | 1 | 2012 | 6 | 0.410 |
Why?
| | Integrase Inhibitors | 1 | 2012 | 1 | 0.400 |
Why?
| | Indoles | 1 | 2014 | 300 | 0.400 |
Why?
| | Cell Line | 11 | 2019 | 2629 | 0.390 |
Why?
| | mRNA Cleavage and Polyadenylation Factors | 2 | 2022 | 26 | 0.380 |
Why?
| | Avian Leukosis Virus | 2 | 2017 | 6 | 0.380 |
Why?
| | Protein Domains | 4 | 2020 | 207 | 0.370 |
Why?
| | RNA, Transfer | 2 | 2016 | 118 | 0.370 |
Why?
| | Archaea | 2 | 2001 | 69 | 0.360 |
Why?
| | Catalytic Domain | 8 | 2016 | 196 | 0.350 |
Why?
| | Nuclear Pore | 2 | 2021 | 14 | 0.340 |
Why?
| | Proteins | 4 | 2020 | 906 | 0.340 |
Why?
| | Peptides | 5 | 2018 | 847 | 0.340 |
Why?
| | Viral Nonstructural Proteins | 3 | 2016 | 54 | 0.330 |
Why?
| | Gene Products, tax | 3 | 2019 | 9 | 0.320 |
Why?
| | RNA-Binding Proteins | 4 | 2018 | 344 | 0.320 |
Why?
| | DNA Footprinting | 1 | 2008 | 28 | 0.320 |
Why?
| | DNA-Binding Proteins | 9 | 2017 | 1311 | 0.320 |
Why?
| | Structure-Activity Relationship | 5 | 2021 | 499 | 0.310 |
Why?
| | Histones | 3 | 2022 | 529 | 0.300 |
Why?
| | Hepacivirus | 3 | 2016 | 228 | 0.300 |
Why?
| | Virus Assembly | 5 | 2022 | 66 | 0.290 |
Why?
| | Salicylates | 2 | 2016 | 30 | 0.280 |
Why?
| | Cytoplasm | 2 | 2021 | 255 | 0.270 |
Why?
| | Molecular Dynamics Simulation | 2 | 2020 | 200 | 0.270 |
Why?
| | Protein Footprinting | 5 | 2011 | 9 | 0.260 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 6 | 2008 | 315 | 0.260 |
Why?
| | Amino Acid Motifs | 4 | 2021 | 197 | 0.260 |
Why?
| | Phosphatidylinositol 4,5-Diphosphate | 1 | 2006 | 24 | 0.260 |
Why?
| | DNA Damage | 4 | 2021 | 351 | 0.260 |
Why?
| | Holliday Junction Resolvases | 8 | 2001 | 8 | 0.260 |
Why?
| | Basic-Leucine Zipper Transcription Factors | 2 | 2017 | 39 | 0.250 |
Why?
| | Ribonuclease H, Human Immunodeficiency Virus | 2 | 2019 | 2 | 0.250 |
Why?
| | Pyridoxal Phosphate | 1 | 2004 | 19 | 0.240 |
Why?
| | Avian Sarcoma Viruses | 1 | 2004 | 4 | 0.240 |
Why?
| | Aptamers, Nucleotide | 2 | 2018 | 73 | 0.240 |
Why?
| | Protein Processing, Post-Translational | 3 | 2017 | 399 | 0.230 |
Why?
| | Ataxia Telangiectasia Mutated Proteins | 3 | 2021 | 62 | 0.230 |
Why?
| | Viral Envelope Proteins | 1 | 2004 | 73 | 0.220 |
Why?
| | Y-Box-Binding Protein 1 | 1 | 2023 | 4 | 0.220 |
Why?
| | Lysine | 7 | 2022 | 241 | 0.220 |
Why?
| | Cell Nucleus | 2 | 2021 | 552 | 0.220 |
Why?
| | Receptors, Virus | 2 | 2019 | 75 | 0.210 |
Why?
| | Magnesium | 3 | 2000 | 144 | 0.210 |
Why?
| | Chromatography, Gel | 4 | 2009 | 122 | 0.210 |
Why?
| | Protein Structure, Quaternary | 4 | 2008 | 115 | 0.210 |
Why?
| | Mutagenesis, Site-Directed | 6 | 2009 | 345 | 0.210 |
Why?
| | Molecular Docking Simulation | 3 | 2019 | 101 | 0.200 |
Why?
| | Xeroderma Pigmentosum Group A Protein | 2 | 2014 | 5 | 0.200 |
Why?
| | Chromosomes, Human | 1 | 2022 | 39 | 0.200 |
Why?
| | Carboxylic Acids | 2 | 2019 | 26 | 0.200 |
Why?
| | Phenylalanine | 1 | 2022 | 57 | 0.200 |
Why?
| | Histone Code | 1 | 2022 | 28 | 0.200 |
Why?
| | Cryoelectron Microscopy | 2 | 2020 | 142 | 0.200 |
Why?
| | Drugs, Investigational | 1 | 2022 | 30 | 0.200 |
Why?
| | Thiophenes | 2 | 2016 | 108 | 0.200 |
Why?
| | Oligonucleotides | 3 | 2018 | 137 | 0.200 |
Why?
| | Proteolysis | 3 | 2017 | 142 | 0.200 |
Why?
| | Protein Subunits | 2 | 2015 | 200 | 0.200 |
Why?
| | Active Transport, Cell Nucleus | 2 | 2021 | 109 | 0.200 |
Why?
| | Drug Discovery | 3 | 2019 | 123 | 0.200 |
Why?
| | Viral Core Proteins | 2 | 2012 | 20 | 0.190 |
Why?
| | RNA | 1 | 2008 | 806 | 0.190 |
Why?
| | Glycine | 1 | 2022 | 152 | 0.190 |
Why?
| | Chromatin | 2 | 2022 | 425 | 0.190 |
Why?
| | HTLV-I Infections | 4 | 2019 | 21 | 0.190 |
Why?
| | Peroxidases | 2 | 1999 | 25 | 0.190 |
Why?
| | Reverse Transcription | 1 | 2021 | 18 | 0.180 |
Why?
| | Lentiviruses, Primate | 1 | 2021 | 13 | 0.180 |
Why?
| | Isoenzymes | 3 | 1999 | 283 | 0.180 |
Why?
| | Purines | 1 | 2002 | 158 | 0.180 |
Why?
| | Poly (ADP-Ribose) Polymerase-1 | 1 | 2021 | 40 | 0.180 |
Why?
| | Tea | 2 | 1997 | 10 | 0.180 |
Why?
| | Enzyme Inhibitors | 1 | 2004 | 743 | 0.180 |
Why?
| | Deuterium Exchange Measurement | 1 | 2020 | 29 | 0.180 |
Why?
| | Cross-Linking Reagents | 2 | 2016 | 179 | 0.180 |
Why?
| | Manganese | 2 | 1999 | 55 | 0.180 |
Why?
| | Necrosis | 1 | 2021 | 209 | 0.170 |
Why?
| | Neuroblastoma | 1 | 2021 | 133 | 0.170 |
Why?
| | Base Sequence | 7 | 2016 | 2114 | 0.170 |
Why?
| | Saccharomyces cerevisiae Proteins | 2 | 2000 | 333 | 0.170 |
Why?
| | Retroviridae Proteins | 2 | 2017 | 11 | 0.170 |
Why?
| | Amino Acid Substitution | 2 | 2013 | 261 | 0.170 |
Why?
| | Adaptor Proteins, Signal Transducing | 2 | 2013 | 367 | 0.170 |
Why?
| | Reverse Transcriptase Inhibitors | 2 | 2011 | 82 | 0.170 |
Why?
| | Stereoisomerism | 1 | 2019 | 91 | 0.160 |
Why?
| | Amino Acids | 1 | 2022 | 445 | 0.160 |
Why?
| | Glucose Transporter Type 1 | 1 | 2019 | 43 | 0.160 |
Why?
| | Gene Products, vpr | 1 | 2018 | 1 | 0.160 |
Why?
| | Myxovirus Resistance Proteins | 1 | 2018 | 8 | 0.160 |
Why?
| | Glycerol | 1 | 2018 | 84 | 0.150 |
Why?
| | Mutation | 6 | 2023 | 3338 | 0.150 |
Why?
| | Substrate Specificity | 4 | 2016 | 350 | 0.150 |
Why?
| | Protein Folding | 2 | 2016 | 239 | 0.150 |
Why?
| | Surface Plasmon Resonance | 1 | 2017 | 81 | 0.140 |
Why?
| | Peroxidase | 1 | 1997 | 161 | 0.140 |
Why?
| | Transcriptional Elongation Factors | 1 | 2017 | 31 | 0.140 |
Why?
| | High Mobility Group Proteins | 1 | 2017 | 49 | 0.140 |
Why?
| | Immunoblotting | 2 | 2016 | 282 | 0.140 |
Why?
| | 5' Untranslated Regions | 2 | 2021 | 51 | 0.140 |
Why?
| | meta-Aminobenzoates | 1 | 2016 | 1 | 0.140 |
Why?
| | alpha-Defensins | 1 | 2016 | 11 | 0.140 |
Why?
| | Nucleocapsid | 1 | 2016 | 17 | 0.140 |
Why?
| | Cyclophilin A | 1 | 2016 | 24 | 0.130 |
Why?
| | Adenosine | 1 | 2018 | 203 | 0.130 |
Why?
| | Protein Structure, Secondary | 3 | 2008 | 325 | 0.130 |
Why?
| | Mutant Proteins | 2 | 2014 | 95 | 0.130 |
Why?
| | DNA Packaging | 1 | 2016 | 22 | 0.130 |
Why?
| | Ribonuclease P | 1 | 2016 | 25 | 0.130 |
Why?
| | DNA, Single-Stranded | 3 | 2006 | 111 | 0.130 |
Why?
| | Hydrophobic and Hydrophilic Interactions | 2 | 2016 | 176 | 0.130 |
Why?
| | Calcium | 2 | 2021 | 1089 | 0.130 |
Why?
| | Dynamic Light Scattering | 1 | 2016 | 6 | 0.130 |
Why?
| | Nucleic Acids | 1 | 2016 | 58 | 0.130 |
Why?
| | Morphogenesis | 1 | 2016 | 159 | 0.130 |
Why?
| | Drug Design | 1 | 2016 | 147 | 0.120 |
Why?
| | NIH 3T3 Cells | 2 | 2013 | 137 | 0.120 |
Why?
| | Spectrometry, Fluorescence | 1 | 2016 | 157 | 0.120 |
Why?
| | Sequence Homology, Amino Acid | 5 | 2005 | 353 | 0.120 |
Why?
| | Animals | 12 | 2021 | 31565 | 0.120 |
Why?
| | Models, Chemical | 1 | 2016 | 248 | 0.120 |
Why?
| | Histidine | 1 | 2014 | 57 | 0.120 |
Why?
| | Microbial Sensitivity Tests | 1 | 2016 | 300 | 0.120 |
Why?
| | Escherichia coli | 4 | 2007 | 723 | 0.120 |
Why?
| | Gene Knockout Techniques | 1 | 2014 | 98 | 0.110 |
Why?
| | Hepatitis C | 1 | 2016 | 218 | 0.110 |
Why?
| | DNA Repair | 2 | 2009 | 184 | 0.110 |
Why?
| | Circular Dichroism | 2 | 2012 | 135 | 0.110 |
Why?
| | High-Throughput Nucleotide Sequencing | 2 | 2014 | 437 | 0.110 |
Why?
| | Nucleoproteins | 2 | 2017 | 27 | 0.110 |
Why?
| | Peptide Mapping | 2 | 2007 | 60 | 0.110 |
Why?
| | Protein Interaction Mapping | 2 | 2012 | 101 | 0.110 |
Why?
| | Carrier Proteins | 1 | 2017 | 694 | 0.110 |
Why?
| | Proto-Oncogene Proteins c-akt | 1 | 2015 | 397 | 0.110 |
Why?
| | Genetic Vectors | 1 | 2014 | 287 | 0.110 |
Why?
| | Hydrolysis | 3 | 2007 | 173 | 0.110 |
Why?
| | Azepines | 1 | 2013 | 69 | 0.110 |
Why?
| | Chromatin Immunoprecipitation | 1 | 2013 | 128 | 0.110 |
Why?
| | Cell Line, Tumor | 2 | 2013 | 2700 | 0.100 |
Why?
| | Genetic Therapy | 1 | 2014 | 256 | 0.100 |
Why?
| | Human T-lymphotropic virus 2 | 1 | 2012 | 1 | 0.100 |
Why?
| | HTLV-II Infections | 1 | 2012 | 2 | 0.100 |
Why?
| | Thermodynamics | 3 | 2020 | 380 | 0.100 |
Why?
| | Gene Expression Regulation, Viral | 3 | 2021 | 80 | 0.100 |
Why?
| | Scattering, Small Angle | 1 | 2012 | 20 | 0.100 |
Why?
| | Calorimetry | 3 | 2001 | 60 | 0.100 |
Why?
| | Indoleacetic Acids | 1 | 2012 | 4 | 0.100 |
Why?
| | X-Ray Diffraction | 1 | 2012 | 84 | 0.100 |
Why?
| | Triazoles | 1 | 2013 | 125 | 0.100 |
Why?
| | Potassium Permanganate | 2 | 2002 | 3 | 0.090 |
Why?
| | RNA Interference | 1 | 2013 | 431 | 0.090 |
Why?
| | Leukemia-Lymphoma, Adult T-Cell | 1 | 2011 | 12 | 0.090 |
Why?
| | Virology | 1 | 2010 | 19 | 0.090 |
Why?
| | Nerve Tissue Proteins | 1 | 2014 | 527 | 0.090 |
Why?
| | Proteasome Endopeptidase Complex | 1 | 2011 | 133 | 0.090 |
Why?
| | DEAD-box RNA Helicases | 1 | 2010 | 56 | 0.090 |
Why?
| | Kinetics | 4 | 2009 | 1547 | 0.090 |
Why?
| | Fluorescence Resonance Energy Transfer | 1 | 2011 | 167 | 0.080 |
Why?
| | DNA Polymerase beta | 1 | 2009 | 5 | 0.080 |
Why?
| | Ribonuclease H | 3 | 2007 | 11 | 0.080 |
Why?
| | Cloning, Molecular | 2 | 2000 | 522 | 0.080 |
Why?
| | Protein Biosynthesis | 1 | 2010 | 386 | 0.080 |
Why?
| | Models, Biological | 3 | 2019 | 1611 | 0.080 |
Why?
| | Furans | 1 | 2008 | 22 | 0.080 |
Why?
| | Tumor Suppressor Proteins | 1 | 2011 | 283 | 0.080 |
Why?
| | Urea | 1 | 2008 | 66 | 0.080 |
Why?
| | Conserved Sequence | 2 | 2017 | 218 | 0.080 |
Why?
| | Autoantigens | 1 | 2011 | 396 | 0.070 |
Why?
| | Neoplasm Proteins | 1 | 2010 | 385 | 0.070 |
Why?
| | Proteomics | 1 | 2013 | 815 | 0.070 |
Why?
| | Nuclear Lamina | 1 | 2007 | 10 | 0.070 |
Why?
| | Retroviridae | 2 | 2010 | 89 | 0.070 |
Why?
| | RNA, Small Interfering | 2 | 2023 | 534 | 0.070 |
Why?
| | RNA Splicing | 2 | 2015 | 244 | 0.070 |
Why?
| | Ultraviolet Rays | 1 | 2009 | 363 | 0.070 |
Why?
| | Phytic Acid | 1 | 2006 | 41 | 0.070 |
Why?
| | Ribonucleoproteins | 2 | 2020 | 85 | 0.070 |
Why?
| | Biotinylation | 1 | 2006 | 26 | 0.070 |
Why?
| | Antimicrobial Cationic Peptides | 1 | 2006 | 75 | 0.060 |
Why?
| | Electron Spin Resonance Spectroscopy | 3 | 1999 | 86 | 0.060 |
Why?
| | Phosphorylation | 3 | 2021 | 1558 | 0.060 |
Why?
| | Inhibitory Concentration 50 | 1 | 2004 | 74 | 0.060 |
Why?
| | Peptide-N4-(N-acetyl-beta-glucosaminyl) Asparagine Amidase | 1 | 2004 | 5 | 0.060 |
Why?
| | Viral Fusion Proteins | 1 | 2004 | 20 | 0.060 |
Why?
| | Calreticulin | 1 | 2004 | 24 | 0.060 |
Why?
| | CD4-Positive T-Lymphocytes | 1 | 2010 | 959 | 0.060 |
Why?
| | Avian Proteins | 1 | 2004 | 20 | 0.060 |
Why?
| | Carbohydrate Metabolism | 1 | 2004 | 48 | 0.060 |
Why?
| | Carbohydrates | 1 | 2004 | 55 | 0.060 |
Why?
| | Oxidation-Reduction | 2 | 1997 | 917 | 0.060 |
Why?
| | Glycosylation | 1 | 2004 | 130 | 0.060 |
Why?
| | Dimerization | 4 | 2007 | 176 | 0.060 |
Why?
| | Chickens | 1 | 2004 | 180 | 0.060 |
Why?
| | Terminal Repeat Sequences | 1 | 2023 | 15 | 0.060 |
Why?
| | Mice | 4 | 2013 | 14843 | 0.050 |
Why?
| | Acetylation | 1 | 2004 | 209 | 0.050 |
Why?
| | Oxazines | 1 | 2023 | 25 | 0.050 |
Why?
| | Genes, Viral | 1 | 2023 | 89 | 0.050 |
Why?
| | Thymine | 1 | 2003 | 12 | 0.050 |
Why?
| | RNA-Directed DNA Polymerase | 1 | 2003 | 34 | 0.050 |
Why?
| | DNA, Fungal | 1 | 2003 | 69 | 0.050 |
Why?
| | Retroelements | 1 | 2003 | 38 | 0.050 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2004 | 924 | 0.050 |
Why?
| | Aspartic Acid | 1 | 2022 | 77 | 0.050 |
Why?
| | Base Pair Mismatch | 1 | 2002 | 14 | 0.050 |
Why?
| | Static Electricity | 1 | 2022 | 112 | 0.050 |
Why?
| | Pyrococcus | 1 | 2001 | 1 | 0.050 |
Why?
| | Methylation | 1 | 2022 | 208 | 0.050 |
Why?
| | Nucleocapsid Proteins | 1 | 2021 | 24 | 0.050 |
Why?
| | Fluorescence Polarization | 1 | 2001 | 35 | 0.050 |
Why?
| | DNA Primers | 2 | 2000 | 508 | 0.050 |
Why?
| | Membrane Proteins | 1 | 2007 | 1016 | 0.050 |
Why?
| | Pyrococcus furiosus | 1 | 2001 | 3 | 0.050 |
Why?
| | Chromatography | 1 | 2001 | 23 | 0.050 |
Why?
| | Enzyme Stability | 2 | 1999 | 62 | 0.050 |
Why?
| | Time Factors | 2 | 2001 | 6077 | 0.040 |
Why?
| | Entropy | 1 | 2020 | 35 | 0.040 |
Why?
| | Peptide Fragments | 1 | 2004 | 665 | 0.040 |
Why?
| | Genes, Archaeal | 1 | 2000 | 6 | 0.040 |
Why?
| | Dogs | 1 | 2021 | 331 | 0.040 |
Why?
| | Candida albicans | 1 | 2000 | 50 | 0.040 |
Why?
| | DNA, Archaeal | 1 | 2000 | 16 | 0.040 |
Why?
| | Saccharomyces cerevisiae | 2 | 2003 | 476 | 0.040 |
Why?
| | Cations, Divalent | 1 | 1999 | 51 | 0.040 |
Why?
| | Phosphoglycerate Mutase | 1 | 1999 | 1 | 0.040 |
Why?
| | Open Reading Frames | 1 | 2000 | 117 | 0.040 |
Why?
| | Sequence Alignment | 1 | 2000 | 323 | 0.040 |
Why?
| | Tumor Cells, Cultured | 1 | 2021 | 845 | 0.040 |
Why?
| | PDZ Domains | 1 | 2019 | 3 | 0.040 |
Why?
| | gag Gene Products, Human Immunodeficiency Virus | 1 | 2019 | 12 | 0.040 |
Why?
| | Sorting Nexins | 1 | 2019 | 10 | 0.040 |
Why?
| | Promoter Regions, Genetic | 1 | 2023 | 1131 | 0.040 |
Why?
| | Lipids | 1 | 2022 | 564 | 0.040 |
Why?
| | G-Quadruplexes | 1 | 2018 | 15 | 0.040 |
Why?
| | Reactive Oxygen Species | 1 | 2021 | 522 | 0.040 |
Why?
| | Molecular Structure | 1 | 2019 | 434 | 0.040 |
Why?
| | Virus Internalization | 1 | 2018 | 40 | 0.040 |
Why?
| | Hot Temperature | 1 | 2000 | 301 | 0.040 |
Why?
| | Virulence | 1 | 2019 | 228 | 0.040 |
Why?
| | Gene Knockdown Techniques | 1 | 2019 | 301 | 0.040 |
Why?
| | Genomics | 1 | 2022 | 631 | 0.040 |
Why?
| | Transfection | 2 | 2012 | 863 | 0.040 |
Why?
| | Ascorbate Peroxidases | 1 | 1997 | 1 | 0.040 |
Why?
| | Salicylic Acid | 1 | 1997 | 8 | 0.040 |
Why?
| | Spectrophotometry, Ultraviolet | 1 | 1997 | 73 | 0.040 |
Why?
| | Tripartite Motif Proteins | 1 | 2017 | 30 | 0.040 |
Why?
| | Point Mutation | 2 | 2009 | 216 | 0.040 |
Why?
| | Cricetulus | 1 | 2017 | 97 | 0.040 |
Why?
| | CHO Cells | 1 | 2017 | 137 | 0.040 |
Why?
| | Gene Products, rex | 1 | 2017 | 1 | 0.030 |
Why?
| | Molecular Weight | 1 | 1997 | 328 | 0.030 |
Why?
| | Plant Proteins | 1 | 1997 | 81 | 0.030 |
Why?
| | Chick Embryo | 1 | 2017 | 122 | 0.030 |
Why?
| | Cell Survival | 2 | 2011 | 1014 | 0.030 |
Why?
| | Potyvirus | 1 | 2016 | 1 | 0.030 |
Why?
| | Simian foamy virus | 1 | 2016 | 2 | 0.030 |
Why?
| | Acyltransferases | 1 | 2017 | 46 | 0.030 |
Why?
| | DNA Viruses | 1 | 2016 | 9 | 0.030 |
Why?
| | beta-Defensins | 1 | 2016 | 18 | 0.030 |
Why?
| | Chemical Precipitation | 1 | 2016 | 37 | 0.030 |
Why?
| | Chemistry Techniques, Synthetic | 1 | 2016 | 12 | 0.030 |
Why?
| | Rats, Sprague-Dawley | 1 | 2021 | 2182 | 0.030 |
Why?
| | Protein Unfolding | 1 | 2016 | 31 | 0.030 |
Why?
| | Molecular Motor Proteins | 1 | 2016 | 33 | 0.030 |
Why?
| | Ubiquitin-Protein Ligases | 1 | 2017 | 139 | 0.030 |
Why?
| | Magnetic Resonance Spectroscopy | 1 | 2018 | 474 | 0.030 |
Why?
| | Protein Stability | 1 | 2016 | 156 | 0.030 |
Why?
| | Molecular Conformation | 1 | 2016 | 135 | 0.030 |
Why?
| | DNA Helicases | 1 | 2016 | 133 | 0.030 |
Why?
| | Signal Transduction | 2 | 2021 | 4501 | 0.030 |
Why?
| | Oxidative Stress | 1 | 2021 | 1068 | 0.030 |
Why?
| | Arginine | 2 | 2007 | 236 | 0.030 |
Why?
| | Introns | 1 | 2015 | 227 | 0.030 |
Why?
| | CpG Islands | 1 | 2014 | 118 | 0.030 |
Why?
| | Genetic Variation | 1 | 2018 | 868 | 0.030 |
Why?
| | Enzyme Activation | 1 | 2015 | 771 | 0.030 |
Why?
| | Sequence Deletion | 1 | 2014 | 166 | 0.030 |
Why?
| | Rats | 1 | 2021 | 4913 | 0.030 |
Why?
| | Mice, Knockout | 2 | 2012 | 2562 | 0.030 |
Why?
| | Tandem Mass Spectrometry | 1 | 2015 | 410 | 0.030 |
Why?
| | Phenotype | 1 | 2020 | 2784 | 0.030 |
Why?
| | Cell Transformation, Viral | 1 | 2012 | 24 | 0.030 |
Why?
| | Heterogeneous-Nuclear Ribonucleoprotein K | 1 | 2012 | 5 | 0.030 |
Why?
| | Protein-Arginine N-Methyltransferases | 1 | 2012 | 16 | 0.030 |
Why?
| | Chromatography, Affinity | 1 | 2012 | 80 | 0.030 |
Why?
| | Nuclear Magnetic Resonance, Biomolecular | 1 | 2014 | 238 | 0.030 |
Why?
| | Apoptosis | 1 | 2021 | 2349 | 0.020 |
Why?
| | Genotype | 1 | 2016 | 1757 | 0.020 |
Why?
| | NF-kappa B | 1 | 2015 | 636 | 0.020 |
Why?
| | Sequence Analysis, DNA | 1 | 2014 | 722 | 0.020 |
Why?
| | G2 Phase | 1 | 2011 | 31 | 0.020 |
Why?
| | Jurkat Cells | 1 | 2011 | 128 | 0.020 |
Why?
| | Proto-Oncogene Proteins c-jun | 1 | 2010 | 47 | 0.020 |
Why?
| | Hydroxyl Radical | 1 | 2011 | 89 | 0.020 |
Why?
| | Macromolecular Substances | 1 | 2010 | 200 | 0.020 |
Why?
| | Multiprotein Complexes | 1 | 2011 | 140 | 0.020 |
Why?
| | Cell Division | 1 | 2011 | 754 | 0.020 |
Why?
| | Combinatorial Chemistry Techniques | 1 | 2008 | 16 | 0.020 |
Why?
| | Nucleotides | 1 | 2009 | 112 | 0.020 |
Why?
| | Fibroblasts | 1 | 2012 | 834 | 0.020 |
Why?
| | Lamin Type A | 1 | 2007 | 40 | 0.020 |
Why?
| | Schiff Bases | 1 | 2006 | 2 | 0.020 |
Why?
| | Tritium | 1 | 2006 | 66 | 0.020 |
Why?
| | DNA Topoisomerases, Type I | 1 | 2006 | 16 | 0.020 |
Why?
| | 5-Hydroxytryptophan | 1 | 2006 | 22 | 0.020 |
Why?
| | Solutions | 1 | 2006 | 144 | 0.020 |
Why?
| | Palmitic Acids | 1 | 2005 | 9 | 0.020 |
Why?
| | Biotin | 1 | 2005 | 20 | 0.020 |
Why?
| | Chymotrypsin | 1 | 2005 | 15 | 0.020 |
Why?
| | Subcellular Fractions | 1 | 2005 | 77 | 0.020 |
Why?
| | Replication Protein A | 1 | 2005 | 11 | 0.020 |
Why?
| | Embryo, Mammalian | 1 | 2005 | 213 | 0.010 |
Why?
| | Tryptophan | 1 | 2005 | 136 | 0.010 |
Why?
| | Plasmids | 1 | 2005 | 343 | 0.010 |
Why?
| | Microscopy, Confocal | 1 | 2005 | 304 | 0.010 |
Why?
| | Microscopy, Fluorescence | 1 | 2005 | 393 | 0.010 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2005 | 328 | 0.010 |
Why?
| | RNA, Fungal | 1 | 2003 | 66 | 0.010 |
Why?
| | RNA Processing, Post-Transcriptional | 1 | 2003 | 82 | 0.010 |
Why?
| | Fluorometry | 1 | 2001 | 19 | 0.010 |
Why?
| | Carbocyanines | 1 | 2001 | 30 | 0.010 |
Why?
| | Cell Membrane | 1 | 2005 | 670 | 0.010 |
Why?
| | Fluorescein | 1 | 2001 | 25 | 0.010 |
Why?
| | Electrophoretic Mobility Shift Assay | 1 | 2001 | 72 | 0.010 |
Why?
| | Energy Transfer | 1 | 2001 | 47 | 0.010 |
Why?
| | Stem Cells | 1 | 2005 | 541 | 0.010 |
Why?
| | Escherichia coli Proteins | 1 | 2001 | 162 | 0.010 |
Why?
| | Enzyme Reactivators | 1 | 1999 | 1 | 0.010 |
Why?
| | Phanerochaete | 1 | 1999 | 3 | 0.010 |
Why?
| | Fluorescent Dyes | 1 | 2001 | 298 | 0.010 |
Why?
| | Spectrophotometry | 1 | 1999 | 47 | 0.010 |
Why?
| | Heme | 1 | 1999 | 52 | 0.010 |
Why?
| | Vanadates | 1 | 1999 | 13 | 0.010 |
Why?
| | RNA Stability | 1 | 2000 | 90 | 0.010 |
Why?
| | Genes, Bacterial | 1 | 1999 | 157 | 0.010 |
Why?
| | Mitochondrial Proteins | 1 | 2000 | 213 | 0.010 |
Why?
| | Ligands | 1 | 2000 | 556 | 0.010 |
Why?
| | Hydrogen-Ion Concentration | 1 | 1999 | 507 | 0.010 |
Why?
| | Temperature | 1 | 1999 | 564 | 0.010 |
Why?
| | Bacterial Proteins | 1 | 2001 | 735 | 0.010 |
Why?
| | Gene Expression | 1 | 1999 | 1417 | 0.010 |
Why?
|
|
Kvaratskhelia's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|